Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Argatroban”

Showing 11 of 0 results

Post-approval studies (Phase 4)Study completedNCT05740371
What this trial is testing

Safety of Argatroban Infusion in Conduction Disturbances

Who this might be right for
Stable Coronary Artery Disease (CAD)Unstable Angina (Troponin Negative)
Tanabe Pharma GmbH 50
Large-scale testing (Phase 3)Ended earlyNCT03809481
What this trial is testing

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Who this might be right for
Heparin-induced Thrombocytopenia
Aspen Global Incorporated 7
Post-approval studies (Phase 4)Study completedNCT03552354
What this trial is testing

Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke

Who this might be right for
Stroke, Ischemic
General Hospital of Shenyang Military Region 120
Not applicableUnknownNCT04751357
What this trial is testing

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Who this might be right for
Heparin-induced Thrombocytopenia
Medical University of Vienna 21
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Large-scale testing (Phase 3)Study completedNCT00198588
What this trial is testing

Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 8
Post-approval studies (Phase 4)Ended earlyNCT01246011
What this trial is testing

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Who this might be right for
Coronary Artery Bypass Graft SurgeryPresence of Heparin/Platelet Factor 4 Antibody
Massachusetts General Hospital 9
Post-approval studies (Phase 4)Ended earlyNCT03506009
What this trial is testing

Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）

Who this might be right for
Argatroban, Rt-PA
Hui-Sheng Chen 3
Testing effectiveness (Phase 2)Study completedNCT01734252
What this trial is testing

Argatroban in Critically Ill Patients With Heparin Resistance

Who this might be right for
Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
Medical University Innsbruck 44
Post-approval studies (Phase 4)Study completedNCT01980316
What this trial is testing

Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting

Who this might be right for
CVD
Xinfeng Liu 114
Not applicableStudy completedNCT04925167
What this trial is testing

Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO

Who this might be right for
Respiratory Failure
Beijing Chao Yang Hospital 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation